• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD8在介导CD8+细胞的免疫调节活性中作为一种抑制性配体发挥作用。

CD8 functions as an inhibitory ligand in mediating the immunoregulatory activity of CD8+ cells.

作者信息

Hambor J E, Kaplan D R, Tykocinski M L

机构信息

Institute of Pathology, Case Western Reserve University, Cleveland, OH 44106.

出版信息

J Immunol. 1990 Sep 15;145(6):1646-52.

PMID:1697305
Abstract

Antisense and sense transfection technologies were employed in cellular coculture systems to investigate the physiologic requirements for CD8-dependent immunoregulation. Our data indicate that cells bearing genetically engineered CD8 molecules incorporating a glycoinositolphospholipid membrane anchor, as well as fixed cells bearing natural CD8 molecules, retain specific, CD8-dependent immunoregulatory activity. These findings together support the novel concept that CD8, a molecule traditionally thought of as a receptor, can function as an inhibitory ligand. CD8-dependent inhibition was shown to induce nonresponsiveness, persisting for at least 24 h, in Ag-specific responders. Moreover, only cells undergoing primary, but not secondary, antigenic stimulation through their TCR were found to be susceptible to CD8-dependent inhibition. Both CD4+ and CD8+ responding T cells were inhibited by CD8+ modulatory cells. These functional analyses of inhibitory and responder cells in CD8-dependent inhibition lay the groundwork for developing artificial CD8-based immunomodulatory peptides and deciphering CD8's role in natural immunoregulation.

摘要

在细胞共培养系统中采用反义及正义转染技术,以研究CD8依赖性免疫调节的生理需求。我们的数据表明,携带经基因工程改造的、含有糖基磷脂酰肌醇膜锚定物的CD8分子的细胞,以及携带天然CD8分子的固定细胞,均保留特异性的、CD8依赖性免疫调节活性。这些发现共同支持了一个新的概念,即传统上被认为是一种受体的CD8分子,可以作为一种抑制性配体发挥作用。已表明,在抗原特异性应答细胞中,CD8依赖性抑制可诱导无反应性,这种无反应性持续至少24小时。此外,发现只有通过其TCR经历初次而非二次抗原刺激的细胞才易受CD8依赖性抑制的影响。CD4+和CD8+应答性T细胞均受到CD8+调节细胞的抑制。对CD8依赖性抑制中的抑制细胞和应答细胞的这些功能分析,为开发基于人工CD8的免疫调节肽以及解读CD8在天然免疫调节中的作用奠定了基础。

相似文献

1
CD8 functions as an inhibitory ligand in mediating the immunoregulatory activity of CD8+ cells.CD8在介导CD8+细胞的免疫调节活性中作为一种抑制性配体发挥作用。
J Immunol. 1990 Sep 15;145(6):1646-52.
2
The roles of CD4 and CD8 in T cell activation.CD4和CD8在T细胞活化中的作用。
Semin Immunol. 1991 May;3(3):133-41.
3
Regulatory function for murine intraepithelial lymphocytes. Two subsets of CD3+, T cell receptor-1+ intraepithelial lymphocyte T cells abrogate oral tolerance.小鼠上皮内淋巴细胞的调节功能。CD3+、T细胞受体-1+上皮内淋巴细胞T细胞的两个亚群可消除口服耐受性。
J Immunol. 1990 Oct 1;145(7):2010-9.
4
Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.可溶性 HLA - A、- B、- C 和 - G 分子可诱导 T 细胞和 NK CD8⁺细胞凋亡,并通过 CD8 连接抑制细胞毒性 T 细胞活性。
Eur J Immunol. 2003 Jan;33(1):125-34. doi: 10.1002/immu.200390015.
5
The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.天然配体驱动未致敏和抗原致敏的CD4+及CD8+T细胞中IL-4表达的能力。
Int Immunol. 2005 Jan;17(1):73-83. doi: 10.1093/intimm/dxh188. Epub 2004 Nov 29.
6
The CD2 ligand LFA-3 activates T cells but depends on the expression and function of the antigen receptor.CD2配体淋巴细胞功能相关抗原-3可激活T细胞,但这依赖于抗原受体的表达和功能。
J Immunol. 1988 Sep 15;141(6):1904-11.
7
Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab.小鼠T淋巴细胞诱导IgG2ab同种异型抑制及T淋巴细胞对IgG2ab耐受的机制。
Arch Immunol Ther Exp (Warsz). 2001;49(6):407-15.
8
Inability of CD8 alpha' polypeptides to associate with p56lck correlates with impaired function in vitro and lack of expression in vivo.CD8α'多肽与p56lck无法结合,这与体外功能受损及体内表达缺失相关。
Nature. 1989 Nov 16;342(6247):278-81. doi: 10.1038/342278a0.
9
Immunoregulatory function of CD3+, CD4-, and CD8- T cells. Gamma delta T cell receptor-positive T cells from nude mice abrogate oral tolerance.CD3 +、CD4 - 和CD8 - T细胞的免疫调节功能。来自裸鼠的γδT细胞受体阳性T细胞消除口服耐受性。
J Immunol. 1989 Dec 1;143(11):3415-22.
10
Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.非抗原特异性CD8 + T抑制淋巴细胞起源于CD8 + CD28 - T细胞,并抑制T细胞增殖和CTL功能。
Hum Immunol. 2004 Feb;65(2):142-56. doi: 10.1016/j.humimm.2003.12.001.

引用本文的文献

1
New designs for cancer vaccine and artificial veto cells: an emerging palette of protein paints.癌症疫苗和人工否决细胞的新设计:一种新兴的蛋白质“颜料”组合。
Immunol Res. 2003;27(2-3):565-74. doi: 10.1385/IR:27:2-3:565.
2
Treatment of an autoimmune disease with "classical" T cell veto: a proposal.用“经典”T细胞否决权治疗自身免疫性疾病:一项提议。
J Clin Immunol. 1999 Jul;19(4):195-202. doi: 10.1023/a:1020511928974.
3
Inhibition of cytotoxic alloreactivity by human allogeneic mononuclear cells: evidence for veto function of CD2+ cells.
人同种异体单个核细胞对细胞毒性同种异体反应性的抑制作用:CD2⁺细胞否决功能的证据。
Immunology. 1998 May;94(1):101-8. doi: 10.1046/j.1365-2567.1998.00480.x.
4
Immunopathology of human inflammatory bowel disease.人类炎症性肠病的免疫病理学
Springer Semin Immunopathol. 1997;18(4):555-89. doi: 10.1007/BF00824058.
5
Antigen-presenting cell engineering. The molecular toolbox.抗原呈递细胞工程。分子工具箱。
Am J Pathol. 1996 Jan;148(1):1-16.
6
AKR.H-2b lymphocytes inhibit the secondary in vitro cytotoxic T-lymphocyte response of primed responder cells to AKR/Gross murine leukemia virus-induced tumor cell stimulation.AKR.H-2b淋巴细胞可抑制经致敏的反应细胞对AKR/格罗斯小鼠白血病病毒诱导的肿瘤细胞刺激产生的体外继发性细胞毒性T淋巴细胞反应。
J Virol. 1996 Jan;70(1):402-14. doi: 10.1128/JVI.70.1.402-414.1996.
7
Ontogeny of rat thymic dendritic cells.大鼠胸腺树突状细胞的个体发生
Immunology. 1994 May;82(1):75-81.
8
The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells.从小鼠胸腺和脾脏中纯化的树突状细胞的表面表型:树突状细胞亚群CD8表达的研究。
J Exp Med. 1992 Jul 1;176(1):47-58. doi: 10.1084/jem.176.1.47.
9
Clonal deletion of postthymic T cells: veto cells kill precursor cytotoxic T lymphocytes.胸腺后T细胞的克隆清除:否决细胞杀死细胞毒性T淋巴细胞前体。
J Exp Med. 1992 Mar 1;175(3):863-8. doi: 10.1084/jem.175.3.863.